Search
NKX101
go.drugbank.com/drugs/DB18131InvestigationalNKX101 is an investigational allogeneic chimeric antigen receptor (CAR)-natural killer cell therapy.
Synonyms: a fourth generation activating chimeric receptor (ACR) natural killer (NK) cell therapy engineered with an NKG2D ACR, OX40 costimulatory domain, CD3zeta signaling moiety, and membrane bound IL-15 (mb-IL15Limonene, (+/-)-
go.drugbank.com/drugs/DB19146InvestigationalLimonene, (+/-)- is under investigation in clinical trial NCT05525260 (Limonene for Pulmonary Nodule Chemoprevention).
Phenazepam
go.drugbank.com/drugs/DB19164InvestigationalPhenazepam is under investigation in clinical trial NCT03017430 (Pregabalin for Opiate Withdrawal Syndrome).
MSX-122
go.drugbank.com/drugs/DB12715InvestigationalMSX-122 has been used in trials studying the treatment of Solid Tumors.
Alvircept sudotox
go.drugbank.com/drugs/DB12786InvestigationalAlvircept Sudotox has been used in trials studying the treatment of HIV Infections.
MK-7622
go.drugbank.com/drugs/DB12897InvestigationalMK-7622 has been used in trials studying the treatment of Alzheimer's Disease.
TT-301
go.drugbank.com/drugs/DB12899InvestigationalTT301 has been used in trials studying the treatment of Traumatic Brain Injury.
XL-888
go.drugbank.com/drugs/DB12981InvestigationalXL888 has been used in trials studying the treatment of Cancer and Melanoma.
LY-518674
go.drugbank.com/drugs/DB12988InvestigationalLY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Henatinib
go.drugbank.com/drugs/DB13019InvestigationalHenatinib has been used in trials studying the treatment of Advanced Solid Cancer.